RxDoctor Payments DataLook up a doctor →

Shaw Zhou, MD

Urology · St Petersburg, FLNPI 1740244565

Payments from drug & device makers

$222,278in general payments, 2019–2025

Across 717 payments — averaging $310.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$72K
  • Astellas Pharma Global Development$70K
  • Axonics, Inc.$52K
  • Medtronic$19K
  • Teleflex LLC$2K
  • Johnson & Johnson$907
  • plus $7K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific34$71,702
Astellas Pharma Global Development20$69,906
Axonics, Inc.186$52,423
Medtronic(2 entities)31$18,705
Teleflex LLC32$1,514
Johnson & Johnson82$907
Astellas Pharma US Inc29$632
AbbVie(2 entities)37$630
Sumitomo Pharma America, Inc.27$604
Dendreon Pharmaceuticals LLC22$506
Pfizer27$505
Coloplast18$479
Endo Pharmaceuticals Inc.14$305
Endo USA, Inc.8$299
Novartis10$246
Palette Life Sciences, Inc.3$238
Urogen Pharma, Inc.10$222
Bayer11$199
Amgen12$195
Antares Pharma, Inc.11$187
Sun Pharmaceutical Industries Inc.4$181
Progenics Pharmaceuticals, Inc.7$177
AstraZeneca4$174
Acerus Pharmaceuticals Corporation8$151
Myovant Sciences Inc.8$142
Urovant Sciences Inc7$140
Neotract Inc.5$112
Telix Pharmaceuticals3$75
Tolmar Pharmaceuticals, Inc.4$64
Fujifilm New Development USA, Inc.2$56
Procept Biorobotics Corporation2$49
Verity Pharmaceuticals Inc.3$48
KARL Storz Endoscopy-america2$45
Merck2$39
Alnylam Pharmaceuticals Inc.1$32
Olympus America Inc.2$29
Immunitybio, Inc.1$29
Tolmar, Inc.2$29
Ferring Pharmaceuticals Inc.2$28
C. R. Bard, Inc. & Subsidiaries1$27
Photocure Inc1$24
Travere Therapeutics, Inc.2$23
Metuchen Pharmaceuticals1$22
Dornier Medtech America, Inc1$22
Bioprotect Medical, Inc.1$18
Cycle Pharmaceuticals Inc1$17
Medivation Field Solutions LLC1$16
Calyxo, Inc.1$15
Laborie Medical Technologies Corp.1$15
Angiodynamics, Inc.1$14
Myriad Genetic Laboratories, Inc.1$14
Blue Earth Diagnostics1$13
Halozyme Inc1$13
Therapeuticsmd, Inc.1$12
Micro-tech Endoscopy USA, Inc.1$10
SN Holdings, LLC5$0
Urogpo LLC2$0

How this compares

$222,278 in reported general payments places this provider in the 95th percentile of 935 urology providers in Florida.

See all urology providers in Florida

Medicare billing

Part B allowed, 2024
$578,920
Medicare patients
631
Services billed
10,836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →